Sun Pharmaceutical Industries Limited — Updates, 17-02-2025: Press Release

Sun Pharmaceutical Industries Limited has been recognized in the S&P Global Sustainability Yearbook 2025, placing it among the top 5% of global pharmaceutical companies assessed on sustainability criteria. This ranking reflects the company’s dedication to Environmental, Social, and Governance (ESG) principles, as articulated by Chairman & Managing Director Dilip Shanghvi. He emphasized the company's commitment to integrating sustainable practices throughout its operations to benefit all stakeholders. The assessment conducted by S&P evaluated over 7,690 companies, with only 780 qualifying for inclusion in the Yearbook, underscoring Sun Pharma's significant achievement in corporate sustainability and its potential positive impact on brand reputation and investor confidence.